Newsroom
Featured News
- Investors16 May 2023
Lotus Reports Strong 1Q 2023 Results with EPS of NT$4.58
- Investors10 May 2023
Monthly sales report for April 2023
- Investors12 April 2023
Monthly sales report for March 2023
- Business27 March 2023
Lotus Announces MFDS Approval for GRALISE® SR, Once-Daily Tablets for Post-Herpetic Neuralgia
- Investors10 March 2023
Lotus’ revenues grow by 16% and profit doubles year over year
- Investors10 March 2023
Lotus hosts fourth quarter 2022 results investor conference
- Investors10 March 2023
Monthly sales report for February 2023
- Business01 March 2023
Lotus is the First to Launch Vinorelbine Soft Gel Capsules in Vietnam
- Charity15 February 2023
Lotus Donates One Million Dollars to Support Turkey and Syria Earthquake Victims
